FDA approves first oral JAK inhibitor for treatment of alopecia areata in adolescents Medha Baranwal28 Jun 2023 8:00 PM ISTUSA: The US FDA (Food and Drug Administration) has approved ritlecitinib (Litfulo), a Janus kinase (JAK) inhibitor, for adults and adolescents with...
Hair loss drug: Pfizer Litfulo for adults, adolescents approved by USFDA Ruchika Sharma24 Jun 2023 11:30 AM ISTLITFULO is a kinase inhibitor which inhibits Janus kinase 3 (JAK3) and the tyrosine kinase expressed in hepatocellular carcinoma (TEC) family of...
Sun Pharma reports consolidated net profit of Rs 1984 crore in Q4 Ruchika Sharma27 May 2023 1:30 PM IST"Several of our businesses, including specialty, India and emerging markets have continued to progress well," Sun Pharma Managing Director Dilip...
USFDA halts Sun Pharma trials on dermatological drug Deuruxolitinib Ruchika Sharma2 May 2023 2:46 PM ISTThe company said it would work closely with the FDA to address the agency's concerns, which the drugmaker expected to be communicated within the next...
Ritlecitinib safe treatment option for alopecia areata in adults and adolescents: Lancet Medha Baranwal24 April 2023 11:30 AM ISTUSA: A recent study published in The Lancet has projected ritlecitinib to be an appropriate treatment option for alopecia areata in individuals who...
Long-term therapy Baricitinib improves hair growth in severe alopecia areata Jacinthlyn Sylvia5 April 2023 8:00 PM ISTA new study published in the American Journal of Clinical Dermatology suggests that Baricitinib's effectiveness for treating people with severe...
Combo of methotrexate and low dose prednisone benefits alopecia areata patients: JAMA Aditi29 March 2023 6:00 AM ISTFrance: An original investigation published in JAMA Dermatology has concluded that, pertaining to the availability of treatment modalities for...
Concert Pharma Deuruxolitinib significantly improves scalp hair regrowth in Alopecia areata, reveals data Ruchika Sharma21 March 2023 1:15 PM ISTDeuruxolitinib is an investigational oral selective inhibitor of Janus kinases JAK1 and JAK2.
Sun Pharma concludes acquisition of Concert Pharma Ruchika Sharma7 March 2023 2:30 PM ISTAcquisition adds Deuruxolitinib for the treatment of alopecia areata, to Sun Pharma’s global dermatology portfolio
Alopecia Areata patients have higher rates of anxiety and depression, says study Aditi3 Feb 2023 8:00 PM ISTThe study demonstrated a strong relationship between Alopecia Areata (AA) patients and two to three times higher anxiety and depression rates than the...
Sun Pharma to buy Concert Pharma for Rs 4678 crore Ruchika Sharma20 Jan 2023 12:26 PM IST"Sun Pharma’s immediate focus would be to follow Concert’s plan to submit a New Drug Application (NDA) to the USFDA in the first half of 2023," the...
Inflammatory bowel disease associated with chronic inflammatory skin diseases Dr.Niharika Harsha B9 Dec 2022 8:00 PM ISTA new study revealed that inflammatory bowel disease was associated with various chronic inflammatory skin diseases. IBD incidence was increased in...
